title: Influenza vaccines and guillain-barre syndrome: the continuing question.
abstract: Influenza is a global public health problem, with complications of seasonal influenza resulting in thousands of deaths and substantial morbidity worldwide. Periodically, particularly virulent viral strains emerge, resulting in more infections and fatalities (e.g., influenza A [H1N1] virus and influenza A/H5N1, "bird flu"). Influenza infection may be prevented or mitigated by vaccination; seasonal vaccine is highly effective in reducing clinical illness and limiting viral spread through respiratory droplets.
authors.affiliation: From the Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
authors.forename: James J
authors.initials: JJ
authors.lastname: Sejvar
mesh_terms: D000818:Animals; D020275:Guillain-Barre Syndrome / Q000209:etiology*; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000150:complications* / Q000628:therapy
chemical_list: D007252:Influenza Vaccines